106 related articles for article (PubMed ID: 2188164)
1. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
Kubasova T; Bank J; Köteles GJ; Horváth M
Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
[TBL] [Abstract][Full Text] [Related]
2. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
[TBL] [Abstract][Full Text] [Related]
3. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
4. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
[TBL] [Abstract][Full Text] [Related]
5. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
6. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
7. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
8. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
9. Early detection of breast cancer by leukocyte adherence inhibition assay.
Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
[TBL] [Abstract][Full Text] [Related]
10. Humoral leukocyte adherence inhibition (H-LAI) with basic encephalitogenic protein (BEP) in head and neck cancer.
Kövesi G; Fekete B
Haematologia (Budap); 1985; 18(1):27-32. PubMed ID: 2581853
[TBL] [Abstract][Full Text] [Related]
11. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
[TBL] [Abstract][Full Text] [Related]
12. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
[TBL] [Abstract][Full Text] [Related]
13. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
14. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
[TBL] [Abstract][Full Text] [Related]
16. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
17. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
Moskaug JO; Kotlar HK; Sanner T
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
[TBL] [Abstract][Full Text] [Related]
18. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
19. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
Varga A; Stosiek P; Kasper M
Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
[TBL] [Abstract][Full Text] [Related]
20. A computerized tube leukocyte adherence inhibition assay in the diagnosis of human lung cancer.
Fink A; Eliraz A; Bruderman I; Wishnitzer R; Shindler D; Shani A; Offer S; Harpaz N; Bentwich Z
Diagn Immunol; 1985; 3(4):171-6. PubMed ID: 2417775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]